THE DIFFERENCES OF BONE METABOLISM IN MALES WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND POSTMENOPAUSAL FEMALES

THE DIFFERENCES OF BONE METABOLISM IN MALES WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND POSTMENOPAUSAL FEMALES

Aim — to compare bone metabolism activity in males with chronic obstructive pulmonary disease (COPD) and postmenopausal females.Materials and methods. The prospective cohort study was conducted. 33 male patients with COPD over 55 years old and 33 female patients without respiratory diseases over 55...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. A. Mardanova, N. I. Kokina, L. L. Sheptulina, A. G. Serova, I. A. Sokolina, V. T. Ivashkin
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	chronic obstructive pulmonary disease postmenopause osteoporosis bone mineral density
Online Access:	https://klinitsist.abvpress.ru/Klin/article/view/69
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correlation of Spinal Deformity Index and Bone Mineral Density in Postmenopausal Osteoporotic Women
by: Baha Çelik, et al.
Published: (2004-03-01)

Time course of bone mineral density changes during 4-year rituximab therapy in postmenopausal women with rheumatoid arthritis
by: T. A. Raskina, et al.
Published: (2015-09-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

Assessment of the Relationship Between Depression and Bone Mineral Density and Quality of Life in Patients with Postmenopausal Osteoporosis
by: Halil Koyuncu, et al.
Published: (2003-09-01)

Effectiveness of Denosumab in Postmenopausal Osteoporosis Treatment: A 1-yr Follow-up Single-center Study
by: Nihal Tezel, et al.
Published: (2021-12-01)

CHANGES OF BONE MINERAL DENSITY DURING FOUR-YEAR RITUXIMAB AND METHOTREXATE THERAPY IN POSTMENOPAUSAL WOMEN WITH RHEUMATOID ARTHRITIS
by: T. A. Raskina, et al.
Published: (2016-12-01)

Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01)

Beyond Bone Mineral Density: Real-World Fracture Risk Profiles and Therapeutic Gaps in Postmenopausal Osteoporosis
by: Anamaria Ardelean, et al.
Published: (2025-08-01)

Quality use of medicines: The postmenopausal woman with osteoporosis
by: Andy Gray, et al.
Published: (2003-05-01)

The relationships between bone turnover markers and bone mineral density in postmenopausal type 2 diabetic women
by: Vadim V. Klimontov, et al.
Published: (2016-11-01)

The Evaluation of Efficacy of Calcitriol on Bone Mineral Density, Pain and Quality of Life in Postmenopausal Osteoporotic Patients With or Without Depression
by: Halil Koyuncu, et al.
Published: (2003-12-01)

Effect of different types of exercise on bone mineral density in postmenopausal women: a systematic review and network meta-analysis
by: Li Xiaoya, et al.
Published: (2025-04-01)

Associations of Arterial Stiffness and Bone Mineral Density in Postmenopausal Women
by: O. Yu. Isaykina, et al.
Published: (2023-03-01)

Clinical features of coronary heart disease in postmenopausal women, depending on the degree of bone mineral density loss
by: N. S. Mykhailovskaya, et al.
Published: (2015-08-01)

Ovariectomy-induced bone loss through inappropriate inflammatory response: an osteoimmunological perspective on postmenopausal osteoporosis
by: Lilika Higuchi, et al.
Published: (2025-05-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Effectiveness of anabolic and anti-resorptive agents for preventing postmenopausal osteoporosis fractures: a systematic review and network meta-analysis
by: Peng Su, et al.
Published: (2025-07-01)

Results of 2-year open multicenter observational study for efficacy, safety, tolerability and quality of life impact of zoledronic acid in women with postmenopausal osteoporosis in real-world settings in Russian Federation
by: O. M. Lesnyak, et al.
Published: (2021-06-01)

Adherence to treatment with denosumab, its efficacy and safety in women with postmenopausal osteoporosis in clinical practice
by: N. V. Toroptsova, et al.
Published: (2016-01-01)

Mapping gut microbiota and metabolite alterations in patients with postmenopausal osteoporosis in the Beijing Community of China
by: Zheng Wang, et al.
Published: (2025-07-01)

MOLECULAR GENETIC TESTING OF OSTEOPOROSIS SUSCEPTIBILITY IN POSTMENOPAUSAL WOMEN IN MOSCOW
by: V A Myakotkin, et al.
Published: (2011-04-01)

Gynoid lean muscle mass as mediator between menarche age, hand grip and bone mineral density in postmenopausal women
by: Miyang Xu, et al.
Published: (2025-05-01)

Impact of the pathogenetic type of postmenopause on the occurrence of tumors of the female reproductive system
by: L. A. Ashrafyan, et al.
Published: (2014-07-01)

THREE YEARS' EXPERIENCE WITH THE BIOLOGICAL AGENT DENOSUMAB USED TO TREAT WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: EFFICACY, SAFETY AND TREATMENT ADHERENCE
by: N. V. Toroptsova, et al.
Published: (2017-07-01)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

The application of FRAX values to determine the distribution of risk factors for Osteoporosis in Postmenopausal women
by: Tri Hari Irfani
Published: (2016-03-01)

Evaluation of changes in bone mass and subclinical atherosclerosis indices in asymptomatic women over a 10-year period
by: I. A. Skripnikova, et al.
Published: (2025-02-01)

The Effects of Denosumab Treatment on Pain and Function Beyond Bone Density in Patients With Postmenopausal Osteoporosis: A Prospective Study
by: Miao Zheng, et al.
Published: (2025-06-01)

STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2017-07-01)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01)

RISK ASSESSMENT FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Z. Shukerova
Published: (2020-12-01)

Cut-off Values of MRI-defined Psoas Muscle Area for Sarcopenia in Postmenopausal Osteoporosis
by: Zeynep Nilufer TEKIN, et al.
Published: (2024-12-01)

Associations of polymorphisms in the gene promoters of cytokines and matrix metalloproteinases with bone mineral density in postmenopausal type 2 diabetic women
by: Olga N. Fazullina, et al.
Published: (2018-03-01)

THE COMPARISON OF PLASMA MALONDIALDEHYDE LEVELS AMONG OSTEOPOROTIC AND NON-OSTEOPOROTIC POSTMENOPAUSAL WOMEN
by: Innawati Jusup, et al.
Published: (2020-11-01)

Analysis of mandible trabecular structure using digital periapical radiographs to assess low bone quality in postmenopausal women
by: Silviana Farrah Diba, et al.
Published: (2021-12-01)

Estimation of Some Biomarkers Related to Bone Turnover in Iraqi Women
by: Wafaa Raji Alfatlawi
Published: (2025-04-01)

A Phase 3 Multicenter, Double‐Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal Osteoporosis
by: Nitin Kapoor, et al.
Published: (2025-06-01)

Estrogenic receptors a and p gene polymorphisms in postmenopausal osteoporosis
by: K A Maslova, et al.
Published: (2008-06-01)

Osteoporosis-related knowledge among Serbian postmenopausal women
by: Vujasinović-Stupar Nada, et al.
Published: (2017-01-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)